Insider · CIK 0001398278
Leanne Kelly
Files at GRI (GRI Bio, Inc.). First filing -, latest -.
In brief
Leanne Kelly files SEC Form 4 as CFO at GRI (GRI Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Leanne Kelly has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | GRI GRI Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +43,222 | $0.00 | $0 | 43,222 | Sep 22, 2025 |
| Aug 26, 2025 | GRI GRI Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,854 | $0.00 | $0 | 11,854 | Aug 27, 2025 |
| Jan 23, 2025 | GRI GRI Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +43,319 | $0.69 | $30k | 43,319 | Jan 24, 2025 |
Questions about Leanne Kelly
Answered from the filings on this page, as of the latest one.
Is Leanne Kelly buying or selling?
Leanne Kelly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Leanne Kelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Leanne Kelly has 0.
Where does Leanne Kelly file Form 4?
Leanne Kelly has filed Form 4 at GRI (GRI Bio, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.